NO940226L - Chirale mellomprodukter for fremstilling av antidiabetiske tiazoler - Google Patents
Chirale mellomprodukter for fremstilling av antidiabetiske tiazolerInfo
- Publication number
- NO940226L NO940226L NO940226A NO940226A NO940226L NO 940226 L NO940226 L NO 940226L NO 940226 A NO940226 A NO 940226A NO 940226 A NO940226 A NO 940226A NO 940226 L NO940226 L NO 940226L
- Authority
- NO
- Norway
- Prior art keywords
- thiazoles
- antidiabetic
- preparation
- chiral intermediates
- trifluoromethylthiazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73354891A | 1991-07-22 | 1991-07-22 | |
PCT/US1992/005434 WO1993002061A1 (en) | 1991-07-22 | 1992-07-01 | Chiral intermediates for the preparation of antidiabetics thiazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
NO940226L true NO940226L (no) | 1994-01-21 |
NO940226D0 NO940226D0 (no) | 1994-01-21 |
Family
ID=24948077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940226A NO940226D0 (no) | 1991-07-22 | 1994-01-21 | Chirale mellomprodukter for fremstilling av antidiabetiske tiazol er |
Country Status (17)
Country | Link |
---|---|
US (1) | US5576442A (xx) |
EP (1) | EP0641331A1 (xx) |
JP (1) | JP2672029B2 (xx) |
KR (1) | KR100214907B1 (xx) |
AU (1) | AU660187B2 (xx) |
CA (1) | CA2111446C (xx) |
FI (1) | FI940307A (xx) |
HU (1) | HUT70422A (xx) |
IE (1) | IE922358A1 (xx) |
IL (1) | IL102575A (xx) |
MX (1) | MX9204277A (xx) |
NO (1) | NO940226D0 (xx) |
NZ (1) | NZ243652A (xx) |
PT (1) | PT100709B (xx) |
TW (1) | TW199892B (xx) |
WO (1) | WO1993002061A1 (xx) |
ZA (1) | ZA925470B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2687149B1 (fr) * | 1992-02-12 | 1995-11-03 | Roussel Uclaf | Nouveaux esters pyrethrinouides derives d'alcools thiazoliques, leur procede de preparation et leur application comme pesticides. |
CA2167287A1 (en) * | 1993-07-16 | 1995-01-26 | George Joseph Quallich | Enantioselective process for thiazole intermediates |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4886814A (en) * | 1986-03-13 | 1989-12-12 | Dr. Karl Thomas Gmbh | Substituted thiazoles and oxazoles and 2-hydroxy-morpholines |
DE3621775A1 (de) * | 1986-03-13 | 1988-01-07 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
US4943635A (en) * | 1987-08-27 | 1990-07-24 | President & Fellows Of Harvard College | Enantioselective reduction of ketones |
US5036079A (en) * | 1989-12-07 | 1991-07-30 | Pfizer Inc. | Hypoglycemic thiazolidinedione derivatives |
AU660701B2 (en) * | 1991-07-22 | 1995-07-06 | Pfizer Inc. | Process for the preparation of intermediates in the synthesis of chiral thiazolidine-2,4-dione derivatives |
-
1992
- 1992-07-01 AU AU23063/92A patent/AU660187B2/en not_active Ceased
- 1992-07-01 JP JP5502811A patent/JP2672029B2/ja not_active Expired - Fee Related
- 1992-07-01 CA CA002111446A patent/CA2111446C/en not_active Expired - Fee Related
- 1992-07-01 EP EP92914850A patent/EP0641331A1/en not_active Withdrawn
- 1992-07-01 KR KR1019940700182A patent/KR100214907B1/ko not_active IP Right Cessation
- 1992-07-01 HU HU9400187A patent/HUT70422A/hu unknown
- 1992-07-01 US US08/162,036 patent/US5576442A/en not_active Expired - Fee Related
- 1992-07-01 WO PCT/US1992/005434 patent/WO1993002061A1/en not_active Application Discontinuation
- 1992-07-07 TW TW081105397A patent/TW199892B/zh active
- 1992-07-20 PT PT100709A patent/PT100709B/pt not_active IP Right Cessation
- 1992-07-21 NZ NZ243652A patent/NZ243652A/en unknown
- 1992-07-21 MX MX9204277A patent/MX9204277A/es not_active IP Right Cessation
- 1992-07-21 IE IE235892A patent/IE922358A1/en not_active Application Discontinuation
- 1992-07-21 ZA ZA925470A patent/ZA925470B/xx unknown
- 1992-07-21 IL IL10257592A patent/IL102575A/en not_active IP Right Cessation
-
1994
- 1994-01-21 FI FI940307A patent/FI940307A/fi unknown
- 1994-01-21 NO NO940226A patent/NO940226D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
IL102575A (en) | 1996-03-31 |
FI940307A0 (fi) | 1994-01-21 |
IE922358A1 (en) | 1993-01-27 |
WO1993002061A1 (en) | 1993-02-04 |
HU9400187D0 (en) | 1994-05-30 |
ZA925470B (en) | 1994-01-21 |
AU660187B2 (en) | 1995-06-15 |
US5576442A (en) | 1996-11-19 |
MX9204277A (es) | 1993-02-01 |
PT100709A (pt) | 1993-09-30 |
NO940226D0 (no) | 1994-01-21 |
PT100709B (pt) | 1999-07-30 |
EP0641331A1 (en) | 1995-03-08 |
CA2111446C (en) | 1997-12-16 |
HUT70422A (en) | 1995-10-30 |
AU2306392A (en) | 1993-02-23 |
TW199892B (xx) | 1993-02-11 |
NZ243652A (en) | 1994-02-25 |
JPH06505026A (ja) | 1994-06-09 |
FI940307A (fi) | 1994-01-21 |
KR100214907B1 (ko) | 1999-08-02 |
JP2672029B2 (ja) | 1997-11-05 |
IL102575A0 (en) | 1993-01-14 |
CA2111446A1 (en) | 1993-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0201742A3 (en) | N-acylpyrrolidine derivatives, processes for preparing them, pharmaceutical composition and use | |
ES2132415T3 (es) | Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol. | |
NO944644L (no) | Fremstilling av 3,4,4-trisubstituert-piperidinyl-N-alkylkarboksylater og mellomprodukter | |
DK356285D0 (da) | Nyt mellemprodukt og fremgangsmaade til fremstilling heraf | |
NO20050408L (no) | Nye camptothecinderivater (CPT-11) og beslektede forbindelser, samt fremgangsmate for fremstilling derav | |
HUT42272A (en) | Insecticides containing derivatives of nitro-methilen and process for production of the derivatives of nitromethilen | |
CA2210022A1 (en) | Paroxetine hydrochloride solvates | |
HUT71798A (en) | Process for preparing pharmaceutical compositions of antidepressant activity containing 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) | |
DE3678736D1 (de) | Labdanderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel. | |
NO981688D0 (no) | Chirale metylfenyloksazolidinoner | |
ES8704445A1 (es) | Procedimiento de preparar derivados aminicos | |
CA2027351A1 (en) | Emulsion of lipid containing a prostaglandin analogue | |
EG19361A (en) | A process for the preparation of piperidine compound having local anaesthetica and analgetic | |
DK546489D0 (da) | Thienopyridin-mevalonolactoner, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat omfattende samme | |
FI940306A0 (fi) | Menetelmä kiraalisten tiatsolidiini-2,4-dionijohdannaisten synteesissä tarvittavien välituotteiden valmistamiseksi | |
NO940226L (no) | Chirale mellomprodukter for fremstilling av antidiabetiske tiazoler | |
ES2106936T3 (es) | Derivados de carbazolona y procedimientos para su preparacion. | |
CA2067341A1 (en) | Method for synthesis of prostaglandin derivatives | |
AU6991696A (en) | 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents | |
WO1998003540A3 (en) | 1,2-substituted cycloalkane derivatives as thrombine inhibitors, a process for the preparation thereof and the use thereof in pharmaceutical formulations | |
PH21322A (en) | Anti-imflammatory polymorphic monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound; composition and method of use therefor | |
EP0268256A3 (en) | 12-halogenated forskolin derivatives, intermediates and a process for the preparation thereof and their use as medicaments | |
SE7610217L (sv) | Kristallint dipilokarpiniumpamoat | |
EG20562A (en) | Process for preparing glutaramide derivatives | |
GB9318790D0 (en) | Heterocyclic derivatives |